Goldman Sachs Maintains Buy on Denali Therapeutics, Lowers Price Target to $82
Goldman Sachs maintains Denali Therapeutics (NASDAQ:DNLI) with a Buy and lowers the price target from $99 to $82.
Stocks That Hit 52-Week Lows On Wednesday
Wednesday's session saw 784 companies set new 52-week lows.
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday, 581 stocks hit new 52-week lows.
Interesting Highlights From Today's 52-Week Lows
Meta Platforms (NASDAQ:FB) was the biggest company on a market cap basis to set a new 52-week low.
